*  Weight Loss Aids | Portsmouth Regional Hospital

Learn more about Weight Loss Aids at Portsmouth Regional Hospital Related Terms Obesity Overweight Weight Control Uses ... A double-blind evaluation of evening primrose oil as an antiobesity agent. Int J Obes. 1983;7:549-553. ... Researchers who study obesity consider it a chronic health condition that must be managed much like high blood pressure or high ... Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998;280:1596- ...

*  Eating disorders/malnutrition - Shop-N-Kart

... in underweight patients or in those taking antiobesity agents or appetite suppressants; and if consuming a high-protein diet. ... Diabetes: Binge-eaters and compulsive eaters have increased risks of developing obesity and type 2 diabetes. ... Laxatives commonly thought of as the safest include bulk-forming agents that contain a crushed seed called psyllium. They are ... Use cautiously if taking anticoagulants (blood thinners) or anti-platelet drugs, immunodepressants or pentobarbital. Use ...

*  Hormonal disorders - Vitamin Life

... antigout agents, anti-inflammatory agents, hydrophilic agents, and chitosan. Use cautiously with diabetes and kidney ... and obesity. ... in underweight patients or in those taking antiobesity agents ... Use cautiously if taking anticoagulants/anti-platelet and blood pressure lowering agents, hormones, antiarrhythmics, ... The gland secretes anti-diuretic hormone (ADH), which controls urine production and manages the water balance in the body. ...

*  Gamma-Linolenic Acid (GLA) | Portsmouth Regional Hospital

A double-blind evaluation of evening primrose oil as an antiobesity agent. Int J Obes. 1983;7:549-553. ... In addition, many participants were known to have "refractory obesity," meaning that they had already failed to respond to ... A double-blind evaluation of evening primrose oil as an antiobesity agent. Int J Obes. 1983;7:549-553. ... tested the unusual hypothesis that evening primrose might only work in individuals with a family history of obesity. 76 The ...

*  Coronary artery disease (CAD) - Capitol Drugs

... antigout agents, anti-inflammatory agents, hydrophilic agents, and chitosan. Use cautiously with diabetes and kidney ... Use cautiously with renal disease, obesity, and psychiatric conditions. Avoid if pregnant or breastfeeding. ... Use cautiously if taking anti-cancer, antioxidant, blood pressure-lowering, or blood thinning agents, or agents that are broken ... cytochrome P450 metabolized agents, menopause agents or oral contraception, or Helicobacter pylori agents. Use cautiously with ...

*  Settler's Country Market Condition Center

... antigout agents, anti-inflammatory agents, hydrophilic agents, and chitosan. Use cautiously with diabetes and kidney ... Infection is most often associated with obesity, diabetes, or having had a previous CABG. Some patients may develop swelling in ... Use cautiously if taking anti-cancer, antioxidant, blood pressure-lowering, or blood thinning agents, or agents that are broken ... cytochrome P450 metabolized agents, menopause agents or oral contraception, or Helicobacter pylori agents. Use cautiously with ...

*  Patent US6399826 - Salts of sibutramine metabolites, methods of making sibutramine metabolites ... - Google Patents

Stock, M.J., Sibutramine: A Review of the Pharmacology of a Novel Anti-Obesity Agent, Int'l J. Obesity, 21(Supp. 1):S25-S29 ( ... antipsychotic agents, anti-anxiolytic agents, β-adrenergic antagonists, 5-HT1A receptor antagonists, and 5-HT3 receptor ... antimonic agents; antipanic agents; cardiovascular agents (e.g., beta blockers and angiotensin converting enzyme inhibitors); ... flavoring agents, preservatives, coloring agents, and the like in the case of oral liquid preparations (such as suspensions, ...

*  Hydroxycitric Acid | Portsmouth Regional Hospital

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998;280:1596- ... Sergio W. A natural food, the malabar tamarind, may be effective in the treatment of obesity. Medical Hypothesis . 1988;27:39- ... Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998;280:1596- ... Thom E. Hydroxycitrate (HCA) in the treatment of obesity [abstract]. Int J Obes Relat Metab Disord. 1996;20(suppl 4):75. ...

*  Serotonin-dopamine reuptake inhibitor - Wikipedia

Oh, Sangmi; Kim, Koon; Chung, Young; Shong, Minho; Park, Seung (2009). "Anti-obesity Agents: A Focused Review on the Structural ... Based on its chemical structure, UWA-101 may actually also possess some activity as a releasing agent, and if so, unlike RTI-83 ... A closely related type of drug is a serotonin-dopamine releasing agent (SDRA). Relative to serotonin-norepinephrine-dopamine ... Hofbauer, Karl (2004). Pharmacotherapy of obesity : options and alternatives. Boca Raton, Fla: CRC Press. ISBN 0-415-30321-4. " ...

*  5-HT2C receptor agonist - Wikipedia

"Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents". Bioorganic & Medicinal ... Staten, M A (2007). "Challenges in the Discovery and Development of New Agents for the Treatment of Obesity". Clinical ... In 1996, dexfenfluramine became the first long-term treatment anti-obesity medication approved in the US; adverse effects ... Obesity is a global epidemic health problem and has received considerable attention as a major public hazard. Obesity is a ...

*  Your Expert Guide To Garcinia Cambogia

... as a potential antiobesity agent: a randomized controlled trial. Journal of the American Medical Association, 280(18), 1596- ... International Journal of Obesity, 26(6), 870.. *Lim, K., Ryu, S., Nho, H. S., Choi, S. K., Kwow, T., Suh, H., ... & Shigematsu ... Ramos, R. R., & Saenz, J. F. (1996). MCF Alarcon Aguilar en,"Control of obesity with Garcinia cambogia extract,". Investigacion ...

*  YM-348 - Wikipedia

Nilsson, BM (2006). "5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents". Journal of Medicinal ... It has thermogenic and anorectic effects in animal studies, making it potentially useful for the treatment of obesity. AL-34662 ... Hayashi, A; Sonoda, R; Kimura, Y; Takasu, T; Suzuki, M; Sasamata, M; Miyata, K (2004). "Antiobesity effect of YM348, a novel 5- ... Smith, BM; Thomsen, WJ; Grottick, AJ (2006). "The potential use of selective 5-HT2C agonists in treating obesity". Expert ...

*  Lipase inhibitors - Patent # 8668921 - PatentGenius

... anti-obesity agents containing procyanidin from tamarind as an active ingredient (Japanese Patent Laying Open Hei 9-291039); as ... Han et al., "Anti-obesity action of oolong tea," Int. J. Obes., 1999, vol. 23, pp. 98-105. cited by applicant.. Iwata et al., " ... Chen et al., "Clinical Efficacy of Oolong Tea on Anti-Simple Obesity," Journal of the Japanese Society of Clinical Nutrition, ... 2002; 132: 1819-1824); and anti-obesity effects of oolong tea extracts in mice (Int. J. Obes. 1999; 23: 98-105).. However, ...

*  Garcinia gummi-gutta - Wikipedia

... as a Potential Antiobesity Agent: A Randomized Controlled Trial". J. Am. Med. Assoc. 280 (18): 1596-1600. doi:10.1001/jama. ... Journal of Obesity. 2011 (December 14): 509038. doi:10.1155/2011/509038. PMC 3010674 . PMID 21197150. Publications & ...

*  Discovery and development of gastrointestinal lipase inhibitors - Wikipedia

... not as an anti-obesity agent. When researchers found out that it promotes less energy uptake, the focus was switched to obesity ... Lipase inhibitors belong to a drug class that is used as an antiobesity agent. Their mode of action is to inhibit gastric and ... For that reason orlistat was chosen over lipstatin for development as an anti-obesity drug. It is the only available FDA- ... Medeiros-Neto, G., A. Halpern, and C. Bouchard, Progress in Obesity Research: 9. Orlistat in the treatment of obesity, ed. A. ...

*  ORBi: Browsing ORBi

Anti-obesity agents should be carefully evaluated in long-term (1-2 years) randomized controlled trials. Recent systematic ... Pharmacologic treatment of obesity, food intake, and reversal of metabolic disorders.. SCHEEN, André ; PAQUOT, Nicolas in ... Anti ... [more ▼]. The present paper is reviewing the current place of weight-reducing drugs in the overall management of ... reviews and meta-analysis assessed both the safety and efficacy of the two drugs currently used in the treatment of obesity, i. ...

*  15 best diet supplements - Nutrition Express Articles

Heymsfield SB, et al., Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. ... 3. Chantre P and Lairon D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. ... Lurz R, et al., Carnitine as supporting agent in weight loss in adiposity. Medical Journal for Natural Therapy 1998, 39(1):12- ... 5. Martinet A, et al., Thermogenic effects of commercially available plant preparations aimed at treating human obesity. ...

*  Hydroxycitric acid - Wikipedia

... as a potential antiobesity agent: a randomized controlled trial". JAMA. 280 (18): 1596-600. doi:10.1001/jama.280.18.1596. PMID ... In a study in Zucker rats, which are genetically predisposed to obesity, Garcinia cambogia extract containing HCA showed that ...

*  Drinabant - Wikipedia

"The current status and future perspectives of studies of cannabinoid receptor 1 antagonists as anti-obesity agents". Current ... Drinabant reached phase IIb clinical trials for this purpose in the treatment of obesity but was shortly thereafter ... which was under investigation varyingly by Sanofi-Aventis as a treatment for obesity, schizophrenia, Alzheimer's disease, ...

*  Rosonabant - Wikipedia

"The current status and future perspectives of studies of cannabinoid receptor 1 antagonists as anti-obesity agents". Current ... Tim C. Kirkham; S. J. Cooper (2007). Appetite and Body Weight: Integrative Systems and the Development of Anti-Obesity Drugs. ... Heal DJ, Gosden J, Smith SL (December 2009). "Regulatory challenges for new drugs to treat obesity and comorbid metabolic ... and suicidal ideation associated with it and with similarly-acting agents. Cannabinoid receptor antagonist Janero DR, ...

*  Velneperit - Wikipedia

Yukioka H. A potent and selective neuropeptide Y Y5-receptor antagonist, S-2367, as an anti-obesity agent. (Japanese). Nihon ... was still considered a successful proof of concept of the potential of Y5 receptor antagonists as possible anti-obesity agents ... doi: 10.1021/acs.oprd.5b00023 George M, Rajaram M, Shanmugam E. New and emerging drug molecules against obesity. J Cardiovasc ... It has anorectic effects and was developed as a possible treatment for obesity, but was discontinued from further development ...

*  Limonin - Wikipedia

Limonin reduces proliferation of colon cancer cells and has been tested as an anti-obesity agent in mice. Yoon, J. S.; Yang, H ... Ono, E.; Inoue, J.; Hashidume, T.; Shimizu, M.; Sato, R. (2011). "Anti-obesity and anti-hyperglycemic effects of the dietary ...

*  Coconut Oil | GreenMedInfo | Substance | Natural Medicine

... topic has 21 study abstracts on Coconut Oil indicating that it may have therapeutic value in the treatment of Abdominal Obesity ... Additional Keywords : Anti-Obesity Agents. [+] Although permethrin lotion is still effective for some people, coconut and anise ... Diseases : Metabolic Syndrome X, Obesity. Pharmacological Actions : Anticholesteremic Agents, Antihypertensive Agents, ... Olive oil contains protective agents that block the expansion of brain core at the expense of penumbral neurons.Oct 31, 2015. ...

*  Most recent papers with the keyword acid-base management | Read by QxMD

Phenolic compounds as natural and multifunctional anti-obesity agents: A review.. Celia Rodríguez-Pérez, Antonio Segura- ... www.readbyqxmd.com/read/29156939/phenolic-compounds-as-natural-and-multifunctional-anti-obesity-agents-a-review ... Prevalence of obesity worldwide has reached pandemic proportions. Despite the increasing evidence in the implication of ... phenolic compounds in obesity management, the real effect is not completely understood. The available in vitro and in vivo ...

*  Adiposopathy - Wikipedia

Bays, HE (2004). "Current and investigational anti-obesity agents and obesity therapeutic treatment targets". Obesity Research ... Regarding drug therapies, it has been stated that: "An emerging concept is that the development of anti-obesity agents must not ... Do you know what the number one health risk in America is? Obesity, obesity They say we're in the middle of an obesity epidemic ... From an anti-inflammatory standpoint, fat tissue produces various anti-inflammatory factors with the most commonly described ...